Skip to Content
Biotechnology and health

Wuhan reported no new coronavirus cases today for the first time

All of the new cases yesterday were imported, Chinese officials said.
March 19, 2020
Wuhan
WuhanAP

The news: Wuhan and its surrounding province, Hubei, had no new cases of coronavirus to report today, according to the Chinese state media. It’s a remarkable turnaround for the city where coronavirus originated, which was only very recently struggling to cope with thousands of sick people requiring hospitalization. All of the 34 new cases recorded the day before were people from abroad, Chinese officials said.

This story is part of our ongoing coverage of the coronavirus/Covid-19 outbreak, which is available free of charge. You can also sign up to our dedicated newsletter.

Cause for optimism? The news from Hubei offers a glimmer of hope, and perhaps some lessons to governments on what works. The main one seems to be the need to put affected populations on strict lockdown at an early stage. This happened in Wuhan: it's still the case that only those with special permission can travel in and out, and people are instructed to stay inside their homes. This order will be lifted only if no additional cases are reported for two consecutive weeks, according to Li Lanjuan, a member of the Chinese Academy of Engineering. It is still possible that cases in Hubei will rebound when authorities eventually relax the lockdown.

A grim milestone: The virus’s epicenter is now arguably Italy, which is set to surpass China’s number of coronavirus-related deaths—3,250—this week. The region of Lombardy has been by far the worst-affected region, with hundreds of people dying every day

Deep Dive

Biotechnology and health

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

An AI-driven “factory of drugs” claims to have hit a big milestone

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology

The quest to legitimize longevity medicine

Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.

There is a new most expensive drug in the world. Price tag: $4.25 million

But will the latest gene therapy suffer the curse of the costliest drug?

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.